Ratings by TD Cowen (Boris peaker)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/16/2024 | MacroGenics | MGNX | Maintain | Hold (N/A) |
|
Details | ||
| 9/12/2024 | Moonlake Immunotherapeutics | MLTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/21/2024 | Aadi Bioscience Inc | AADI | Downgrade | Hold (Buy) |
1.56 (2.05) |
31.41% | Details | |
| 8/15/2024 | Celcuity Inc | CELC | Maintain | Buy (N/A) |
|
Details | ||
| 7/26/2024 | Glycomimetics | GLYC | Downgrade | Hold (Buy) |
0.24 (0.16) |
-33.33% | Details | |
| 5/10/2024 | MacroGenics | MGNX | Downgrade | Hold (Buy) |
14.67 (2.23) |
-84.8% | Details | |
| 4/16/2024 | Fusion Pharmaceuticals | FUSN | Downgrade | Hold (Buy) |
21.28 (21.55) |
1.27% | Details | |
| 4/16/2024 | Alpine Immune Sciences | ALPN | Downgrade | Hold (Buy) |
64.42 (64.97) |
0.85% | Details | |
| 4/9/2024 | MacroGenics | MGNX | Upgrade | Buy (Hold) |
18.35 (14.67) |
-20.05% | Details | |
| 12/12/2023 | Alpine Immune Sciences | ALPN | Maintain | Buy (N/A) |
|
Details | ||
| 12/5/2023 | UroGen Pharma | URGN | Maintain | Buy (N/A) |
|
Details | ||
| 12/4/2023 | Lantheus Holdings | LNTH | New Coverage | Buy (N/A) |
73.79 (72.56) |
-1.67% | Details | |
| 11/15/2023 | Heron Therapeutics | HRTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2023 | ADC Therapeutics | ADCT | Downgrade | Hold (Buy) |
0.60 (4.11) |
585% | Details | |
| 5/19/2023 | Emergent BioSolutions | EBS | Maintain | Hold (N/A) |
|
Details | ||
| 4/18/2023 | Vaxcyte | PCVX | New Coverage | Buy (N/A) |
42.34 (59.29) |
40.03% | Details | |
| 4/17/2023 | CTI BioPharma | CTIC | Maintain | Buy (N/A) |
|
Details | ||
| 3/21/2023 | Seagen | SGEN | Maintain | Hold (N/A) |
|
Details | ||
| 11/22/2022 | MacroGenics | MGNX | Downgrade | Hold (Buy) |
6.37 (18.35) |
188.07% | Details | |
| 11/9/2022 | Emergent BioSolutions | EBS | Maintain | Hold (N/A) |
|
Details | ||
| 10/28/2022 | Seagen | SGEN | Maintain | Hold (N/A) |
|
Details | ||
| 9/12/2022 | Emergent BioSolutions | EBS | Maintain | Hold (N/A) |
|
Details | ||
| 8/9/2022 | Heron Therapeutics | HRTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/18/2022 | Seagen | SGEN | Maintain | Hold (N/A) |
|
Details | ||
| 7/7/2022 | Moonlake Immunotherapeutics | MLTX | New Coverage | Buy (N/A) |
5.58 (18.15) |
225.27% | Details | |
| 7/7/2022 | CTI BioPharma | CTIC | New Coverage | Buy (N/A) |
6.00 (9.09) |
51.5% | Details | |
| 6/17/2022 | POINT Biopharma Global Inc. | PNT | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2022 | Heron Therapeutics | HRTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2022 | NuCana | NCNA | Downgrade | Hold (Buy) |
2.94 (2.16) |
-26.53% | Details | |
| 3/1/2022 | Heron Therapeutics | HRTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2022 | Emergent BioSolutions | EBS | Maintain | Hold (N/A) |
|
Details | ||
| 2/4/2022 | Jounce Therapeutics | JNCE | Upgrade | Buy (Hold) |
7.12 (1.88) |
-73.6% | Details | |
| 10/25/2021 | ERYTECH Pharma SA. | ERYP | Downgrade | Hold (Buy) |
5.48 (0.78) |
-85.77% | Details | |
| 10/1/2021 | Aadi Bioscience Inc | AADI | New Coverage | Buy (N/A) |
29.37 (1.56) |
-94.69% | Details | |
| 8/13/2021 | Tscan Therapeutics Inc | TCRX | New Coverage | Buy (N/A) |
10.09 (1.12) |
-88.9% | Details | |
| 7/29/2021 | Celcuity Inc | CELC | New Coverage | Buy (N/A) |
20.50 (115.00) |
460.98% | Details | |
| 7/29/2021 | POINT Biopharma Global Inc. | PNT | New Coverage | Buy (N/A) |
9.00 (12.50) |
38.89% | Details | |
| 5/13/2021 | Heron Therapeutics | HRTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/22/2021 | Emergent BioSolutions | EBS | Maintain | Hold (N/A) |
|
Details | ||
| 1/5/2021 | Mersana | MRSN | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2020 | Emergent BioSolutions | EBS | Maintain | Hold (N/A) |
|
Details | ||
| 9/14/2020 | Seattle Genetics | SGEN | Maintain | Hold (N/A) |
|
Details | ||
| 8/26/2020 | Alpine Immune Sciences | ALPN | New Coverage | Buy (N/A) |
8.60 (64.97) |
655.47% | Details | |
| 7/31/2020 | Seattle Genetics | SGEN | Maintain | Hold (N/A) |
|
Details | ||
| 7/21/2020 | Fusion Pharmaceuticals | FUSN | New Coverage | Buy (N/A) |
15.28 (21.55) |
41.03% | Details | |
| 7/16/2020 | Seattle Genetics | SGEN | Maintain | Hold (N/A) |
|
Details | ||
| 7/16/2020 | Emergent BioSolutions | EBS | Maintain | Hold (N/A) |
|
Details | ||
| 7/13/2020 | Aimmune Therapeutics | AIMT | New Coverage | Buy (N/A) |
15.68 (34.49) |
119.96% | Details | |
| 6/29/2020 | Heron Therapeutics | HRTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/9/2020 | ADC Therapeutics | ADCT | New Coverage | Buy (N/A) |
35.25 (4.11) |
-88.34% | Details | |
| 6/8/2020 | Emergent BioSolutions | EBS | Maintain | Hold (N/A) |
|
Details | ||
| 5/1/2020 | Seattle Genetics | SGEN | Maintain | Hold (N/A) |
|
Details | ||
| 5/1/2020 | Emergent BioSolutions | EBS | Maintain | Hold (N/A) |
|
Details | ||
| 3/27/2020 | Glycomimetics | GLYC | New Coverage | Buy (N/A) |
2.40 (0.24) |
-90% | Details | |
| 1/14/2020 | Seattle Genetics | SGEN | Maintain | Hold (N/A) |
|
Details | ||
| 11/7/2019 | Emergent BioSolutions | EBS | Maintain | Hold (N/A) |
|
Details | ||
| 10/30/2019 | Seattle Genetics | SGEN | Maintain | Hold (N/A) |
|
Details | ||
| 10/30/2019 | Seattle Genetics | SGEN | Maintain | Hold (N/A) |
|
Details | ||
| 5/2/2019 | Heron Therapeutics | HRTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2019 | Seattle Genetics | SGEN | Maintain | Hold (N/A) |
|
Details | ||
| 11/5/2018 | Clearside Biomedical | CLSD | Downgrade | Hold (Buy) |
5.56 (0.41) |
-92.63% | Details | |
| 10/22/2018 | Sutro Biopharma | STRO | New Coverage | Buy (N/A) |
14.55 (25.29) |
73.81% | Details | |
| 10/16/2018 | Y-mAbs Therapeutics | YMAB | New Coverage | Buy (N/A) |
20.81 (8.61) |
-58.63% | Details | |
| 10/2/2018 | Emergent BioSolutions | EBS | Maintain | Hold (N/A) |
|
Details | ||
| 10/1/2018 | Seattle Genetics | SGEN | Maintain | Hold (N/A) |
|
Details |
